Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1992 1
1993 1
1995 1
1996 2
1998 5
1999 2
2000 2
2001 3
2002 3
2003 4
2004 8
2005 4
2006 6
2007 3
2008 5
2009 4
2010 9
2011 6
2012 10
2013 11
2014 10
2015 8
2016 5
2017 11
2018 9
2019 7
2020 7
2021 6
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

150 results
Results by year
Filters applied: . Clear all
Page 1
Reply to Assoc. Prof. Kocak.
Willén L, Berglund A, Bergström S, Isaksson J, Bergqvist M, Wagenius G, Lambe M. Willén L, et al. Among authors: bergqvist m. Acta Oncol. 2022 Mar;61(3):320. doi: 10.1080/0284186X.2021.2023216. Epub 2022 Jan 11. Acta Oncol. 2022. PMID: 35012418 No abstract available.
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
Huang H, Georganaki M, Conze LL, Laviña B, van Hooren L, Vemuri K, van de Walle T, Ramachandran M, Zhang L, Pontén F, Bergqvist M, Smits A, Betsholtz C, Dejana E, Magnusson PU, He L, Lugano R, Dimberg A. Huang H, et al. Among authors: bergqvist m. Neuro Oncol. 2022 Mar 12;24(3):398-411. doi: 10.1093/neuonc/noab181. Neuro Oncol. 2022. PMID: 34347079 Free PMC article.
Esophageal cancer: current and emerging therapy modalities.
Ekman S, Dreilich M, Lennartsson J, Wallner B, Brattström D, Sundbom M, Bergqvist M. Ekman S, et al. Among authors: bergqvist m. Expert Rev Anticancer Ther. 2008 Sep;8(9):1433-48. doi: 10.1586/14737140.8.9.1433. Expert Rev Anticancer Ther. 2008. PMID: 18759695 Review.
150 results